Chong Kun Dang Pharmaceutical

This study compares two diabetes drugs, empagliflozin and glimepiride, added to standard treatment in 200 adults with type 2 diabetes. The goal is to see which combination better controls blood sugar without causing low blood sugar or weight gain. Participants must be over 19 and…

This early-stage study tests two drugs, CKD-215 and D215, in 24 adults aged 19-75 with advanced BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer. The goal is to compare how the body processes each drug and check for side effects. Participants will receive both d…

This early-stage trial tests a new drug called CKD-846 in 32 healthy men with benign prostate hypertrophy (enlarged prostate). The main goal is to see how the drug moves through the body and if it is safe. Participants must be men aged 19 to 55 with a healthy weight.